Acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) are
characterized by rapid-onset respiratory failure following a variety of direct and indirect …

Abstract Background The Japanese Society of Respiratory Care Medicine and the Japanese
Society of Intensive Care Medicine provide here a clinical practice guideline for the …

Rationale: Experimental data suggest that manipulation of alveolar fluid clearance with β-
agonists can accelerate the resolution of alveolar edema and improve survival. Objective: To …

Multiple studies have identified an expansion and morphological dysregulation of the
bronchial vascular network in the airways of asthmatics. Increased number, size and density …

Background: Acute lung injury is an important cause of respiratory failure in the critically ill
patient. It is caused by damage to the alveolar barrier with subsequent alveolar flooding …

Over 50 years have passed since the acute respiratory distress syndrome (ARDS) was first
described. 1 Despite the passage of more than one-half of a century, almost all of ARDS …

As a syndrome of injurious pulmonary inflammation resulting in deranged respiratory
physiology, acute lung injury affords numerous potential therapeutic targets. Two main …

Inhaled long-acting β-adrenergic agonists (LABAs) and short-acting β-adrenergic agonists
are approved for the treatment of obstructive lung disease via actions mediated by β 2 …

The acute respiratory distress syndrome (ARDS) is a devastating constellation of clinical,
radiological and pathological signs characterized by failure of gas exchange and refractory …

BACKGROUND Acute respiratory distress syndrome (ARDS) is a major cause of mortality in
intensive care patients and lacks effective treatments. A previous randomised controlled …